Petco Health and Wellness Company, Inc. (FRA:7G9)

FRA:7G9 Statistics

Total Valuation

FRA:7G9 has a market cap or net worth of EUR 734.53 million. The enterprise value is 3.08 billion.

Market Cap	734.53M
Enterprise Value	3.08B

Important Dates

The last earnings date was Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	243.10M
Shares Outstanding	n/a
Shares Change (YoY)	+2.51%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	33.41%
Float	89.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	12.75
PS Ratio	0.14
PB Ratio	0.73
P/TBV Ratio	n/a
P/FCF Ratio	6.54
P/OCF Ratio	3.30
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.12, with an EV/FCF ratio of 27.45.

EV / Earnings	-1,620.15
EV / Sales	0.60
EV / EBITDA	4.12
EV / EBIT	26.87
EV / FCF	27.45

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.57.

Current Ratio	0.91
Quick Ratio	0.25
Debt / Equity	2.57
Debt / EBITDA	3.49
Debt / FCF	22.91
Interest Coverage	0.86

Financial Efficiency

Return on equity (ROE) is -0.19% and return on invested capital (ROIC) is 1.74%.

Return on Equity (ROE)	-0.19%
Return on Assets (ROA)	1.38%
Return on Invested Capital (ROIC)	1.74%
Return on Capital Employed (ROCE)	2.80%
Revenue Per Employee	179,334
Profits Per Employee	-66
Employee Count	29,000
Asset Turnover	1.15
Inventory Turnover	5.63

Taxes

Income Tax	-2.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.11%
50-Day Moving Average	2.87
200-Day Moving Average	2.74
Relative Strength Index (RSI)	48.76
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.43

Income Statement

In the last 12 months, FRA:7G9 had revenue of EUR 5.20 billion and -1.90 million in losses. Loss per share was -0.01.

Revenue	5.20B
Gross Profit	2.01B
Operating Income	99.49M
Pretax Income	-4.10M
Net Income	-1.90M
EBITDA	271.83M
EBIT	99.49M
Loss Per Share	-0.01

Balance Sheet

The company has 205.84 million in cash and 2.57 billion in debt, giving a net cash position of -2.37 billion.

Cash & Cash Equivalents	205.84M
Total Debt	2.57B
Net Cash	-2.37B
Net Cash Per Share	n/a
Equity (Book Value)	1.00B
Book Value Per Share	3.57
Working Capital	-83.28M

Cash Flow

In the last 12 months, operating cash flow was 222.40 million and capital expenditures -110.03 million, giving a free cash flow of 112.37 million.

Operating Cash Flow	222.40M
Capital Expenditures	-110.03M
Free Cash Flow	112.37M
FCF Per Share	n/a

Margins

Gross margin is 38.57%, with operating and profit margins of 1.91% and -0.04%.

Gross Margin	38.57%
Operating Margin	1.91%
Pretax Margin	-0.08%
Profit Margin	-0.04%
EBITDA Margin	5.23%
EBIT Margin	1.91%
FCF Margin	2.16%

Dividends & Yields

FRA:7G9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.51%
Shareholder Yield	-2.51%
Earnings Yield	-0.26%
FCF Yield	15.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:7G9 has an Altman Z-Score of 1.04 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.04
Piotroski F-Score	5